CompaniesDeNovaMed

DeNovaMed

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

0

As Collaborator

6

Total Enrollment

206

By Phase

NA: 6

By Status

WITHDRAWN: 2COMPLETED: 2TERMINATED: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
NCT02617160
NCT03003806
NCT04014569
NCT03774069
Hover over trial bars to see details

Recent Trials

NCT04904718Collaborator
Real World Evaluation of Advisor Pro in Clinical Practice
NAWithdrawn
Started: Dec 31, 2021 · Completed: Dec 31, 2021
NCT03774069Collaborator
The Advisor Pro Direct Study
NAWithdrawn
Started: Dec 1, 2020 · Completed: Dec 1, 2023
NCT03574558Collaborator
Personalized Automated Determination of Insulin Pump Setting for Subjects With Type 1 Diabetes Switching From MDI to Pump Therapy and Vice Versa- Safety and Efficacy Feasibility Study
NACompleted
28 participants
Started: Aug 1, 2018 · Completed: Nov 25, 2019
NCT04014569Collaborator
Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
NATerminated
6 participants
Started: May 2, 2018 · Completed: Sep 1, 2020
NCT03003806Collaborator
Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study
NACompleted
122 participants
Started: Oct 2, 2017 · Completed: Nov 10, 2019
View all 6 trials →